Bioceres Crop Solutions Corp. (BIOX)

NASDAQ: BIOX · IEX Real-Time Price · USD
12.65
+0.16 (1.28%)
At close: Mar 27, 2024, 4:00 PM
12.67
+0.02 (0.16%)
After-hours: Mar 27, 2024, 4:00 PM EDT

Total Valuation

BIOX has a market cap or net worth of $756.52 million. The enterprise value is $951.71 million.

Market Cap 756.52M
Enterprise Value 951.71M

Important Dates

The next estimated earnings date is Wednesday, May 8, 2024, after market close.

Earnings Date May 8, 2024
Ex-Dividend Date n/a

Share Statistics

BIOX has 62.83 million shares outstanding. The number of shares has decreased by -0.73% in one year.

Shares Outstanding 62.83M
Shares Change (YoY) -0.73%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 51.09%
Owned by Institutions (%) 29.94%
Float 12.95M

Valuation Ratios

The trailing PE ratio is 35.69 and the forward PE ratio is 10.07.

PE Ratio 35.69
Forward PE 10.07
PS Ratio 1.68
Forward PS 1.42
PB Ratio 2.52
P/FCF Ratio 111.52
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.70, with an EV/FCF ratio of 140.29.

EV / Earnings 43.35
EV / Sales 2.11
EV / EBITDA 12.70
EV / EBIT 17.05
EV / FCF 140.29

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.79.

Current Ratio 1.24
Quick Ratio 0.85
Debt / Equity 0.79
Debt / EBITDA 3.16
Debt / FCF 34.88
Interest Coverage 1.75

Financial Efficiency

Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 9.08%.

Return on Equity (ROE) 7.30%
Return on Assets (ROA) 2.70%
Return on Capital (ROIC) 9.08%
Revenue Per Employee $1.13M
Profits Per Employee $54,888
Employee Count 400
Asset Turnover 0.55
Inventory Turnover 1.85

Taxes

In the past 12 months, BIOX has paid $2.00 million in taxes.

Income Tax 2.00M
Effective Tax Rate 8.33%

Stock Price Statistics

The stock price has increased by +14.58% in the last 52 weeks. The beta is 0.56, so BIOX's price volatility has been lower than the market average.

Beta (1Y) 0.56
52-Week Price Change +14.58%
50-Day Moving Average 13.11
200-Day Moving Average 12.33
Relative Strength Index (RSI) 42.74
Average Volume (30 Days) 70,503

Short Selling Information

Short Interest 291,181
Short Previous Month 294,321
Short % of Shares Out 0.46%
Short % of Float 2.25%
Short Ratio (days to cover) 2.73

Income Statement

In the last 12 months, BIOX had revenue of $450.32 million and earned $21.96 million in profits. Earnings per share was $0.35.

Revenue 450.32M
Gross Profit 189.36M
Operating Income 53.23M
Pretax Income 23.95M
Net Income 21.96M
EBITDA 74.96M
EBIT 55.81M
Earnings Per Share (EPS) $0.35
Full Income Statement

Balance Sheet

The company has $41.44 million in cash and $236.64 million in debt, giving a net cash position of -$195.19 million or -$3.11 per share.

Cash & Cash Equivalents 41.44M
Total Debt 236.64M
Net Cash -195.19M
Net Cash Per Share -$3.11
Equity / Book Value 300.54M
Book Value Per Share 4.78
Working Capital 75.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $29.61 million and capital expenditures -$22.82 million, giving a free cash flow of $6.78 million.

Operating Cash Flow 29.61M
Capital Expenditures -22.82M
Free Cash Flow 6.78M
FCF Per Share $0.11
Full Cash Flow Statement

Margins

Gross margin is 42.05%, with operating and profit margins of 11.82% and 4.88%.

Gross Margin 42.05%
Operating Margin 11.82%
Pretax Margin 5.32%
Profit Margin 4.88%
EBITDA Margin 16.65%
EBIT Margin 12.39%
FCF Margin 1.51%

Dividends & Yields

BIOX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.73%
Shareholder Yield 0.73%
Earnings Yield 2.90%
FCF Yield 0.90%

Analyst Forecast

The average price target for BIOX is $20.33, which is 60.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.33
Price Target Difference 60.71%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 20.99%
EPS Growth Forecast (5Y) 52.86%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7